Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
contrast agent |
| gptkbp:activeIngredient |
gptkb:gadopentetate_dimeglumine
|
| gptkbp:approvedBy |
gptkb:FDA
1988 |
| gptkbp:ATCCode |
V08CA01
|
| gptkbp:CASNumber |
86050-77-3
|
| gptkbp:chemicalFormula |
C28H54GdN5O20
|
| gptkbp:contraindication |
severe renal impairment
|
| gptkbp:eliminationHalfLife |
1.6 hours
|
| gptkbp:excretion |
renal
|
| https://www.w3.org/2000/01/rdf-schema#label |
Magnevist
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Bayer_Healthcare
|
| gptkbp:molecularWeight |
938.0 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:riskFactor |
gptkb:nephrogenic_systemic_fibrosis
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
headache allergic reaction |
| gptkbp:usedFor |
magnetic resonance imaging
|
| gptkbp:bfsParent |
gptkb:Bayer_HealthCare
|
| gptkbp:bfsLayer |
6
|